Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the appointment of James Christensen, Ph.D., as Chief Executive Officer. The post Terremoto Biosciences Appoints James Christensen, Ph.D., as Chief Executive Officer first appeared on Terremoto .